Paul Dziwis
Gastroenterology · Rochester, NYNPI 1134102700
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.4% of the total across 315 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Johnson & Johnson at 29.5% of the total. Reporting peaked in 2021 at $1,458 and has fallen 98.9% since, to $17 in 2023.
Across 315 payments — averaging $10.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$947
- AbbVie$645
- Takeda Pharmaceuticals U.S.A., Inc.$278
- Pfizer$212
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$185
- UCB, Inc.$174
- plus $771 from 15 others
What the payments were for
- Food & beverage$3,09896%
- Education$1164%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 171 | $947 |
| AbbVie | 38 | $645 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $278 |
| Pfizer | 19 | $212 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $185 |
| UCB, Inc. | 9 | $174 |
| Bristol Myers Squibb | 8 | $104 |
| Braintree Laboratories, Inc. | 5 | $101 |
| Nestle Healthcare Nutrition Inc. | 5 | $90 |
| Merck | 6 | $81 |
| QOL Medical, LLC | 4 | $69 |
| Intercept Pharmaceuticals, Inc. | 4 | $65 |
| Gilead | 4 | $57 |
| Cook Medical LLC | 3 | $44 |
| Ironwood Pharmaceuticals, Inc | 3 | $39 |
| Ferring Pharmaceuticals Inc. | 2 | $28 |
| AstraZeneca | 2 | $25 |
| Redhill Biopharma Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Aries Pharmaceuticals, Inc. | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
How this compares
$3,214 in reported general payments places this provider in the 60th percentile of 1,682 gastroenterology providers in New York.
Other gastroenterology in Rochester
- Vivek KaulRochester$226K
- Jeffrey GoldsteinRochester$214K
- David Carr LockeNew York$2M
- Arthur KornbluthNew York$1.9M
- Maya SrivastavaWilliamsville$1.8M
- Melissa PalmerPlainview$1M
- Sonal KumarNew York$1M
- David PoppersNew York$939K
- Ellen ScherlNew York$857K
- Bruce SandsNew York$810K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.